Walgreens has entered into a $300 million settlement with the U.S. Justice Department and related agencies to resolve allegations of illegally filling millions of invalid prescriptions for opioids and other controlled substances. The companyâs actions violated the Controlled Substances Act and led to improper claims being made for reimbursement from Medicare and other federal healthcare programs. As part of the settlement, Walgreens has agreed to maintain compliance measures for seven years and faces additional penalties up to $50 million if sold or merged before 2032.
Walgreens has agreed to a $300 million settlement with U.S. authorities over allegations of illegally filling invalid prescriptions for opioids and other controlled substances.
The settlement addresses claims that Walgreens pharmacists knowingly filled millions of unlawful prescriptions and sought payment from federal healthcare programs for these violations.
In addition to the financial settlement, Walgreens must implement compliance measures over the next seven years to prevent future violations related to prescription practices.
Walgreens faces potential further penalties of up to $50 million if the company undergoes a sale, merger, or transfer before 2032.
Collection
[
|
...
]